The Man in Room 117
Andrey Shevelyov would rather live on the street than take antipsychotic medication. Should it be his decision to make? (Source: NYT Health)
Source: NYT Health - January 28, 2024 Category: Consumer Health News Authors: Ellen Barry Tags: Mental Health and Disorders Group Homes and Supportive Housing Psychiatry and Psychiatrists Zyprexa (Drug) Homeless Persons Prisons and Prisoners Drugs (Pharmaceuticals) Vancouver (Wash) Washington (State) United States your-feed-healt Source Type: news
Olanzapine Effective for Higher-Risk Chemo-Induced Nausea Olanzapine Effective for Higher-Risk Chemo-Induced Nausea
The antipsychotic improves on standard antiemetic therapy in patients known to be more prone to nausea and vomiting with chemotherapy.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 8, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
Low-Dose Olanzapine Improves Appetite in Chemotherapy Patients Low-Dose Olanzapine Improves Appetite in Chemotherapy Patients
Low-dose olanzapine appears to be an effective and well-tolerated add-on intervention for the subset of patients at risk for anorexia at the start of chemotherapy, say researchers.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 6, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Olanzapine poisoning in patients treated at the National Poison Control Centre in Belgrade, Serbia in 2017 and 2018: a brief review of serum concentrations and clinical symptoms - Đorđević S, Vukcević NP, Antunović M, Kilibarda V, Ercegović GV, Stosić JJ, Vucinić S.
Olanzapine is a thienobenzodiazepine class antipsychotic that strongly antagonises the 5-HT2A serotonin receptor, but acute poisonings are reported rarely. Symptoms of an overdose include disorder of consciousness, hypersalivation, myosis, and coma. Serum ... (Source: SafetyLit)
Source: SafetyLit - July 11, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
COVID-19 May Be Linked to Spontaneous Psychosis. Researchers Are Trying to Figure Out Why
In May 2020, a 33-year-old mother of three in North Carolina started experiencing symptoms of COVID-19. Four days later, a different set of symptoms set in. She stopped sleeping well and started having paranoid delusions that people were tracking her through her cell phone—culminating in a frantic scene at a fast-food restaurant, in which she tried to pass her children through the drive-through window, where they’d be safe from the phones and other dangers.
A restaurant employee called 911, and emergency medical services workers arrived, gathered up the family, and hurried to the nearby emergency department of...
Source: TIME: Health - March 4, 2022 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Cost-effectiveness of midazolam versus haloperidol versus olanzapine for the management of acute agitation in the accident and emergency department - Yan VKC, Haendler M, Lau H, Li X, Lao KSJ, Tsui SH, Yap CYL, Knapp MRJ, Chan EW.
OBJECTIVES: A multicenter randomized clinical trial in Hong Kong Accident and Emergency (A&E) departments concluded that intramuscular (IM) olanzapine is noninferior to haloperidol and midazolam, in terms of efficacy and safety, for the management of acute... (Source: SafetyLit)
Source: SafetyLit - February 15, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Lybalvi (Olanzapine and Samidorphan Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 7, 2021 Category: Drugs & Pharmacology Source Type: news
Lybalvi (Olanzapine and Samidorphan Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 4, 2021 Category: Drugs & Pharmacology Source Type: news
FDA Approves Lybalvi (olanzapine and samidorphan) for the Treatment of Schizophrenia and Bipolar I Disorder
DUBLIN, June 1, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved Lybalvi (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the treatment... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 1, 2021 Category: Drugs & Pharmacology Source Type: news
FDA Okays New Drug Option for Schizophrenia, Bipolar I Disorder FDA Okays New Drug Option for Schizophrenia, Bipolar I Disorder
The FDA has approved a once-daily oral medication, which is a combination of olanzapine and samidorphan (Lybalvi, Alkermes), for the treatment of schizophrenia and bipolar 1 disorder.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2021 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news
Olanzapine-induced aggression - Smith D, Gautam M, Krayem B.
There are sparse case reports of olanzapine-induced manic or hypomanic symptoms. There are limited to no case reports of olanzapine-induced aggression, apart from some cases of agitation noted after the ingestion of olanzapine ranging from 30 mg to 840 mg.... (Source: SafetyLit)
Source: SafetyLit - May 20, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Comunicado de la FDA sobre la seguridad de los medicamentos: La evaluaci ón de un estudio por parte de la FDA esclarece dos muertes relacionadas con el fármaco inyectable para el tratamiento de la esquizofrenia Zyprexa Relprevv (pamoato de olanzapina)
[03-23-2015] La Administraci ón de Alimentos y Medicamentos (FDA, por sus siglas en inglés) ha finalizado la evaluación del estudio llevado a cabo para determinar la causa de los niveles elevados del fármaco inyectable para el tratamiento de la esquizofrenia Zyprexa Relprevv (pamoato de olanzapina) en dos pacientes que fall ecieron. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 29, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
The importance of conduct disorder in the treatment of violence in schizophrenia: efficacy of clozapine compared with olanzapine and haloperidol - Krakowski M, Tural U, Czobor P.
This study is a... (Source: SafetyLit)
Source: SafetyLit - January 25, 2021 Category: International Medicine & Public Health Tags: Violence and Weapons Issues Source Type: news
Use of intramuscular chlorpromazine versus intramuscular olanzapine for the management of acute agitation and aggression in youth - Snyder SD, Williams A, Mitchell M, Kneebusch J.
OBJECTIVES: In the inpatient psychiatric setting, one treatment strategy used to manage acute agitation in youth includes administration of IM antipsychotics. The aim of this study was to compare the effectiveness and safety of IM chlorpromazine versus IM ... (Source: SafetyLit)
Source: SafetyLit - January 13, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Olanzapine Helps Manage Nausea and Vomiting in Patients with Advanced Cancer
This trial found that olanzapine may help patients with advanced cancer successfully manage nausea and vomiting unrelated to chemotherapy. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
